UBISOFT Entertainment header image

UBISOFT Entertainment

UBI

Equity

ISIN FR0000054470 / Valor 491199

Euronext - Euronext Paris (2026-08-28)
EUR 5.30-1.52%

UBISOFT Entertainment
UMushroom community rating:

star star star star star
3.00 1 votes No rating yet
NegativeNeutralPositive

About company

Ubisoft Entertainment is a multinational company engaged in the creation, development, and publishing of video games. It operates a network of studios worldwide, with a workforce of approximately 17,000 employees, and focuses on both developing original titles and licensing high-profile games. Recently, the company secured cloud streaming rights for a major slate of games—including titles like Call of Duty—through an agreement contingent on the completion of Microsoft’s acquisition of Activision Blizzard, positioning these titles on its Ubisoft+ service as well as through licensing to other digital gaming platforms. Additionally, Ubisoft invests in technological tools that enhance accessibility in gaming, such as its open-source colorblind simulation software, supporting developers in creating more inclusive content.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (18.08.2026):

UBISOFT Entertainment — Q4 FY2025-26 (and full-year FY2025-26): The company reported full-year net bookings of €1,525.1m (down 17.4% y/y) and Q4 net bookings of €415.0m (€25m above guidance but down 54% y/y versus a record prior-year quarter). FY2025-26 showed large operating losses: IFRS operating income €(1,322.3)m and non‑IFRS operating income €(1,044.7)m, with non‑IFRS diluted EPS of €(9.38). Liquidity improved materially after a €1.16bn strategic cash injection (Tencent transaction), leaving cash ≈€1.345bn and non‑IFRS net debt of €(187.3)m at March 31, 2026. Management is executing a major strategic reset (portfolio rationalization, leadership changes and cost cuts) and forecasts FY2026-27 as a low point for free cash flow before a rebound to positive FCF in FY2027-28 and robust FCF in FY2028-29.

Headline financials

Full-year IFRS 15 sales €1,395.7m (‑21.8% y/y); net bookings €1,525.1m (‑17.4% y/y). Non‑IFRS operating loss €(1,044.7)m vs €(15.1)m in FY2024-25. IFRS diluted EPS €(11.16); non‑IFRS diluted EPS €(9.38).

Q4 performance

Q4 net bookings €415m, beating guidance (~€390m) driven by back‑catalog strength, but down ~54% y/y against a prior‑year quarter that included Assassin’s Creed Shadows and higher partnership revenue.

Cash, debt and the Tencent transaction

Cash and equivalents ≈€1.345bn at March 31, 2026; non‑IFRS net debt improved to €(187.3)m from €(885.1)m a year earlier, helped by the €1.16bn strategic transaction with Tencent which materially deleveraged the Group.

Cash flow and liquidity outlook

Non‑IFRS cash flows from operating activities were a net outflow of €408.2m in FY2025-26. Guidance for FY2026-27: Free Cash Flow consumption of no more than €500m and sufficient liquidity to address near‑term maturities while management reviews financing options.

Back‑catalog & Live services

Back‑catalog remained resilient (full‑year back‑catalog net bookings €1,281.8m); strong live performance from Rainbow Six Siege, The Division 2 and Avatar expansion contributed to Q4 strength and growing MAUs (36m MAUs; annual unique users ~129m excluding XDefiant).

Cost reduction & organization

Fixed cost base down €118m vs FY2024-25 and ~€325m cumulative reduction since FY2022-23; headcount down ~1,200 to 16,590. Targeting €500m cumulative run‑rate savings by March 2028 and further rightsizing (7 projects cancelled, 6 delayed).

Product quality & roadmap

Recent releases show quality gains (Assassin’s Creed Shadows, Anno 117: Pax Romana and Avatar expansion all >80 Metacritic). FY2026-27 slate is lighter (e.g., Assassin’s Creed Black Flag Resynced on July 9, 2026) with a bigger content pipeline expected in FY2027-28 and FY2028-29.

Guidance and strategic outlook

For FY2026-27 Ubisoft expects net bookings down by a high single‑digit percentage, a high single‑digit negative non‑IFRS operating margin and FCF consumption ≤€500m; management expects a return to positive FCF and non‑IFRS EBIT in FY2027-28 and robust FCF in FY2028-29, with positive cumulative FCF over FY2026-27 to FY2028-29.

Summarized from source with an LLMView Source

Key figures

-44.4%1Y
-81.5%3Y
-90.1%5Y

Performance

78.1%1Y
62.8%3Y
56.3%5Y

Volatility

Market cap

828 M

Market cap (USD)

Daily traded volume (Shares)

328,030

Daily traded volume (Shares)

1 day high/low

13 / 12.735

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
2.00
Benoît Noël
Switzerland, 17 Mar 2026
star star star star star
Good games

EQUITIES OF THE SAME SECTOR

MSA Safety Inc
MSA Safety Inc MSA Safety Inc Valor: 23909487
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%USD 190.34
Q2 Holdings Inc
Q2 Holdings Inc Q2 Holdings Inc Valor: 23733115
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%USD 65.13
ODDITY Tech Ltd.
ODDITY Tech Ltd. ODDITY Tech Ltd. Valor: 128034307
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.27%USD 14.35
SentinelOne Inc
SentinelOne Inc SentinelOne Inc Valor: 111988326
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.15%USD 21.54
Spyre Therapeutics Inc
Spyre Therapeutics Inc Spyre Therapeutics Inc Valor: 129513338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.48%USD 90.36
Iovance Biotherapeutics Inc
Iovance Biotherapeutics Inc Iovance Biotherapeutics Inc Valor: 37313485
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.03%USD 8.01
Palo Alto Networks Inc
Palo Alto Networks Inc Palo Alto Networks Inc Valor: 18379378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.96%USD 375.33
Klaviyo Inc
Klaviyo Inc Klaviyo Inc Valor: 129329789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.75%USD 20.15
Sezzle Inc
Sezzle Inc Sezzle Inc Valor: 129105133
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.34%USD 124.12
Mphasis Limited
Mphasis Limited Mphasis Limited Valor: 1354290
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.04%INR 2,452.75